PetMed Express Q4 EPS $0.29 Beats $0.14 Estimate, Sales $62.40M Miss $65.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
PetMed Express reported Q4 earnings of $0.29 per share, beating the analyst consensus estimate of $0.14 by 107.14%. However, quarterly sales of $62.40 million missed the estimate of $65.90 million by 5.31%, a 5.46% decrease YoY.
May 22, 2023 | 8:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
PetMed Express Q4 earnings beat estimates, but sales missed expectations and decreased 5.46% YoY.
PetMed Express reported better-than-expected earnings, but missed sales estimates and experienced a YoY decrease. This mixed result may lead to a neutral short-term impact on the stock price, as the positive earnings beat is offset by the negative sales performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100